USPTO serial 79398350
SEQURNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 17, 2025
- Examiner
- SEVERSON, JUSTIN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEQURNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas Y. Yee
Thomas Y. Yee Perkins Coie LLPP.O. Box 2608Seattle, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for medical research; diagnostic reagents for scientific use; reagents for research purposes. | ACTIVE | — |
| 005 | Reagents for medical use; clinical diagnostic reagents for medical use; diagnostic reagents for medical use; reagents for use with analyzers for medical purposes; diagnostic biomarker reagents for medical purposes; clinical medical reagents; reagent paper for medical purposes; RNase inhibitors for medical purposes | ACTIVE | — |
| 010 | Medical instruments, namely, vials containing RNase inhibitors used for RNA sequencing; instruments for use in medical analysis, namely, vials containing RNase inhibitors used for RNA sequencing; testing instruments for medical purposes, namely, vials containing RNase inhibitors used for RNA sequencing; diagnostic instruments for medical purposes, namely, vials containing RNase inhibitors used for RNA sequencing; apparatus for DNA and RNA exams for medical purposes; capillary tubes for delivering reagents for medical use | ACTIVE | — |
| 042 | Scientific, medical and pharmaceutical research and development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to molecular biology and biomedicine; medical and scientific consulting services in the fields of molecular biology and biomedicine; providing medical and scientific research information in the field of molecular biology and biomedicine; pharmaceutical and scientific research and development; laboratory diagnostics, namely, medical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories; medical and scientific information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SEQURNA AB
- Other trademarks owned by Sequrna AB
- Other trademarks owned by Sequrna AB
- Other trademarks owned by Sequrna AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SEQURNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 5, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 16, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 16, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 11, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 26, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 19, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 17, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 17, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 31, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 31, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 31, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 31, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 20, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 20, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 20, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 7, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 14, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 12, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 11, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 28, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |